Needle-Free mRNA Vaccines Show Success Against Flu and COVID-19 in Mice
Researchers have successfully vaccinated mice against both influenza and Covid-19 without using a needle. The method uses the speed of the liquid to cross the skin’s surface, bypassing the conventional syringes typically required for immunizations.
-
Key Clinical Takeaways:
- A needle-free jet delivery system was tested on mice to administer messenger RNA without lipid nanoparticles.
- Researchers combined aluminium phosphate and short DNA fragments as adjuvants to stimulate an immune response.
- After three doses, viable virus levels in the lungs of exposed mice dropped below the detection threshold for both pathogens.
Needle-Free Delivery and Adjuvant Combinations Tested in Laboratory Mice
Traditional mRNA vaccines rely on tiny fatty particles known as lipid nanoparticles to protect the genetic instructions and help them cross cellular membranes. The experimental approach tested by the research team removed these lipid carriers entirely to simplify vaccine preparation. However, delivering naked messenger RNA triggers an insufficiently weak immune reaction. To solve this hurdle, the investigators added two distinct immune-boosting substances: aluminium phosphate and short fragments of DNA. While each substance provided minimal improvement independently, combining them significantly amplified the immune response in the animal subjects.
Following a three-dose regimen, the researchers exposed the immunized mice to the coronavirus responsible for Covid-19 and to influenza viruses. Lung tissue analyses showed that the quantity of virus capable of infecting cells dropped below detection limits. Investigators noted that this needle-free preparation caused fewer inflammatory reactions in these trials compared to certain experimental formulations utilizing fatty particles. Nevertheless, scientists emphasized that these findings remain strictly experimental and do not yet prove equivalent human tolerability.
Public Health Infrastructure Mobilizes for Winter Viral Protection
Hospitals are also establishing outreach initiatives to address vaccine hesitancy. The Michel-Mazéas Hospital in Douarnenez scheduled its third vaccination day for Friday, November 6, 2026, providing free, walk-in access for influenza and Covid-19 immunizations. Dr. Lydie Khatchatourian, an infectious disease physician and vaccinologist, and head of the public health pole at the Centre hospitalier de Cornouaille, highlighted the importance of reaching out to hesitant individuals and young workers who accompany elderly relatives. These public health measures aim to interrupt transmission chains before peak respiratory infection season saturates emergency rooms and primary care offices.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.
